Cytokine Storm Market
Cytokine release syndrome (CRS) is a form of systemic inflammatory response syndrome (SIRS) that ... Read More
Casimersen is an investigational compound being developed by Sarepta Therapeutics to treat Duchenne muscular dystrophy (DMD) patients with mutations amenable to exon 45 skipping.
This report contains market size and forecasts of Casimersen in global, including the following market information:
Global Casimersen Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Casimersen Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Casimersen companies in 2021 (%)
The global Casimersen market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Casimersen include Sarepta Therapeutics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Casimersen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Casimersen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Casimersen Market Segment Percentages, by Type, 2021 (%)
Injection
Others
Global Casimersen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Casimersen Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Casimersen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Casimersen Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Casimersen revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Casimersen revenues share in global market, 2021 (%)
Key companies Casimersen sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Casimersen sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sarepta Therapeutics
Cytokine release syndrome (CRS) is a form of systemic inflammatory response syndrome (SIRS) that ... Read More
Cytokine release syndrome (CRS) is a form of systemic inflammatory response syndrome (SIRS) that ... Read More
Surgical instrument tracking system is a combination of latest scanning technology and applicatio ... Read More
RFID helps to mitigate drug counterfeiting, simplifies the clinical trial process, improves the ... Read More